Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03032627 · ClinicalTrials.gov registry record · NA
Identifying Targets of Maladaptive Metabolic Responses in Heart Failure
A NA study of Heart Failure, sponsored by AdventHealth Translational Research Institute.
- Active
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT03032627 is a NA study of Heart Failure that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 55 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03032627, a NA study of Heart Failure, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to help researchers understand changes in metabolism in patients that develop heart failure.
Conditions Studied
Interventions
- PROCEDURE Collection of discarded heart tissue
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-03-20 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03032627
The ClinicalTrials.gov registry entry for NCT03032627 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Collection of discarded heart tissue is the first listed.
NCT03032627 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03032627 about?
NCT03032627 is a clinical study titled "Identifying Targets of Maladaptive Metabolic Responses in Heart Failure". The purpose of the research is to help researchers understand changes in metabolism in patients that develop heart failure.
What is the current status of trial NCT03032627?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2017-03-20. Estimated completion is 2025-12.
What conditions does trial NCT03032627 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03032627?
The interventions under investigation include: Collection of discarded heart tissue (PROCEDURE).
Who is sponsoring clinical trial NCT03032627?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03032627 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.